Patent Challenge. 6.5.1 Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, upon the commencement by Licensee or any of its Affiliates of a Patent Challenge.
Appears in 24 contracts
Samples: Option and License Agreement, License Agreement, License Agreement (Prevail Therapeutics Inc.)
Patent Challenge. 6.5.1 Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, upon the commencement by Licensee or Licensee, any of its Affiliates Affiliates, or any Sublicensee of a Patent Challenge.
Appears in 3 contracts
Samples: License Agreement (AveXis, Inc.), License Agreement (AveXis, Inc.), License Agreement (REGENXBIO Inc.)
Patent Challenge. 6.5.1 6.6.1 Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, upon the commencement by Licensee or any of its Affiliates of a Patent Challenge.
Appears in 2 contracts
Samples: License Agreement (Prevail Therapeutics Inc.), License Agreement (Rocket Pharmaceuticals, Inc.)
Patent Challenge. 6.5.1 6.7.1 Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, upon the commencement by Licensee or any of its Affiliates of a Patent Challenge.
Appears in 2 contracts
Samples: License Agreement (Audentes Therapeutics, Inc.), License Agreement (Audentes Therapeutics, Inc.)
Patent Challenge. 6.5.1 Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, upon the commencement by Licensee or Licensee, any of its Affiliates Affiliates, or any Sublicensee of a Patent Challenge. * * * * CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITHRESPECT TO THE OMITTED PORTIONS.
Appears in 2 contracts
Samples: License Agreement, License Agreement (AveXis, Inc.)
Patent Challenge. 6.5.1 Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, upon the commencement by Licensee or any of its Affiliates of a Patent Challenge. ****Certain information has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 1 contract
Samples: License Agreement (REGENXBIO Inc.)
Patent Challenge. 6.5.1 6.6.1 Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, upon the commencement by Licensee or Licensee, any of its Affiliates or any Sublicensees of a Patent Challenge.
Appears in 1 contract
Patent Challenge. 6.5.1 6.6.1 Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, upon the commencement by Licensee or Licensee, any of its Affiliates Affiliates, or any Sublicensee of a Patent Challenge.
Appears in 1 contract
Patent Challenge. 6.5.1 Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, upon the commencement by Licensee or Licensee, any of its Affiliates Affiliates, or any Sublicensee of a Patent Challenge.. ****CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. CONFIDENTIAL TREATMENT REQUESTED
Appears in 1 contract
Samples: License Agreement (REGENXBIO Inc.)
